Literature DB >> 8421693

Paradoxical structure and function in a mutant human insulin associated with diabetes mellitus.

Q X Hua1, S E Shoelson, K Inouye, M A Weiss.   

Abstract

The solution structure of a diabetes-associated mutant human insulin (insulin Los Angeles; PheB24-->Ser) was determined by 13C-edited NMR spectroscopy and distance-geometry/simulated annealing calculations. Among vertebrate insulins PheB24 is invariant, and in crystal structures the aromatic ring appears to anchor the putative receptor-binding surface through long-range packing interactions in the hydrophobic core. B24 substitutions are of particular interest in relation to the mechanism of receptor binding. In one analogue ([GlyB24]insulin), partial unfolding of the B chain has been observed with paradoxical retention of near-native bioactivity. The present study of [SerB24]insulin extends this observation: relative to [GlyB24]insulin, near-native structure is restored despite significant loss of function. To our knowledge, our results provide the first structural study of a diabetes-associated mutant insulin and support the hypothesis that insulin undergoes a change in conformation on receptor binding.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8421693      PMCID: PMC45707          DOI: 10.1073/pnas.90.2.582

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Supernormal insulin: [D-PheB24]-insulin with increased affinity for insulin receptors.

Authors:  M Kobayashi; S Ohgaku; M Iwasaki; H Maegawa; Y Shigeta; K Inouye
Journal:  Biochem Biophys Res Commun       Date:  1982-07-16       Impact factor: 3.575

2.  Rhombohedral insulin crystal transformation.

Authors:  G Bentley; G Dodson; A Lewitova
Journal:  J Mol Biol       Date:  1978-12-25       Impact factor: 5.469

3.  Decreased biologic activity and degradation of human [SerB24]-insulin, a second mutant insulin.

Authors:  M Haneda; M Kobayashi; H Maegawa; N Watanabe; Y Takata; O Ishibashi; Y Shigeta; K Inouye
Journal:  Diabetes       Date:  1985-06       Impact factor: 9.461

4.  Identification of a mutant human insulin predicted to contain a serine-for-phenylalanine substitution.

Authors:  S Shoelson; M Fickova; M Haneda; A Nahum; G Musso; E T Kaiser; A H Rubenstein; H Tager
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

5.  Familial hyperinsulinemia due to a structurally abnormal insulin. Definition of an emerging new clinical syndrome.

Authors:  M Haneda; K S Polonsky; R M Bergenstal; J B Jaspan; S E Shoelson; P M Blix; S J Chan; S C Kwok; W B Wishner; A Zeidler
Journal:  N Engl J Med       Date:  1984-05-17       Impact factor: 91.245

6.  Single chain des-(B30) insulin. Intramolecular crosslinking of insulin by trypsin catalyzed transpeptidation.

Authors:  J Markussen; K H Jørgensen; A R Sørensen; L Thim
Journal:  Int J Pept Protein Res       Date:  1985-07

7.  Diabetes due to secretion of a structurally abnormal insulin (insulin Wakayama). Clinical and functional characteristics of [LeuA3] insulin.

Authors:  K Nanjo; T Sanke; M Miyano; K Okai; R Sowa; M Kondo; S Nishimura; K Iwo; K Miyamura; B D Given
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

8.  Mutations at the dimer, hexamer, and receptor-binding surfaces of insulin independently affect insulin-insulin and insulin-receptor interactions.

Authors:  S E Shoelson; Z X Lu; L Parlautan; C S Lynch; M A Weiss
Journal:  Biochemistry       Date:  1992-02-18       Impact factor: 3.162

9.  Three mutant insulins in man.

Authors:  S Shoelson; M Haneda; P Blix; A Nanjo; T Sanke; K Inouye; D Steiner; A Rubenstein; H Tager
Journal:  Nature       Date:  1983-04-07       Impact factor: 49.962

10.  Receptor binding redefined by a structural switch in a mutant human insulin.

Authors:  Q X Hua; S E Shoelson; M Kochoyan; M A Weiss
Journal:  Nature       Date:  1991-11-21       Impact factor: 49.962

View more
  12 in total

1.  Effect of external stresses on protein conformation: a computer modelling study.

Authors:  A Budi; S Legge; H Treutlein; I Yarovsky
Journal:  Eur Biophys J       Date:  2003-10-23       Impact factor: 1.733

2.  Enhancing the activity of a protein by stereospecific unfolding: conformational life cycle of insulin and its evolutionary origins.

Authors:  Qing-xin Hua; Bin Xu; Kun Huang; Shi-Quan Hu; Satoe Nakagawa; Wenhua Jia; Shuhua Wang; Jonathan Whittaker; Panayotis G Katsoyannis; Michael A Weiss
Journal:  J Biol Chem       Date:  2009-03-25       Impact factor: 5.157

3.  Inactive conformation of an insulin despite its wild-type sequence.

Authors:  G Kurapkat; E De Wolf; J Grötzinger; A Wollmer
Journal:  Protein Sci       Date:  1997-03       Impact factor: 6.725

4.  The solution structure of a superpotent B-chain-shortened single-replacement insulin analogue.

Authors:  G Kurapkat; M Siedentop; H G Gattner; M Hagelstein; D Brandenburg; J Grötzinger; A Wollmer
Journal:  Protein Sci       Date:  1999-03       Impact factor: 6.725

5.  Comparative studies on the dynamics of crosslinked insulin.

Authors:  P Krüger; J Hahnen; A Wollmer
Journal:  Eur Biophys J       Date:  1994       Impact factor: 1.733

Review 6.  INS-gene mutations: from genetics and beta cell biology to clinical disease.

Authors:  Ming Liu; Jinhong Sun; Jinqiu Cui; Wei Chen; Huan Guo; Fabrizio Barbetti; Peter Arvan
Journal:  Mol Aspects Med       Date:  2014-12-24

7.  Protective hinge in insulin opens to enable its receptor engagement.

Authors:  John G Menting; Yanwu Yang; Shu Jin Chan; Nelson B Phillips; Brian J Smith; Jonathan Whittaker; Nalinda P Wickramasinghe; Linda J Whittaker; Vijay Pandyarajan; Zhu-li Wan; Satya P Yadav; Julie M Carroll; Natalie Strokes; Charles T Roberts; Faramarz Ismail-Beigi; Wieslawa Milewski; Donald F Steiner; Virander S Chauhan; Colin W Ward; Michael A Weiss; Michael C Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

8.  Mutant INS-gene induced diabetes of youth: proinsulin cysteine residues impose dominant-negative inhibition on wild-type proinsulin transport.

Authors:  Ming Liu; Leena Haataja; Jordan Wright; Nalinda P Wickramasinghe; Qing-Xin Hua; Nelson F Phillips; Fabrizio Barbetti; Michael A Weiss; Peter Arvan
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

9.  Selective covalent capture of collagen triple helices with a minimal protecting group strategy.

Authors:  Le Tracy Yu; Jeffrey D Hartgerink
Journal:  Chem Sci       Date:  2022-02-17       Impact factor: 9.825

Review 10.  Understanding insulin and its receptor from their three-dimensional structures.

Authors:  Michael C Lawrence
Journal:  Mol Metab       Date:  2021-05-13       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.